Due to its significant market share and high gross margins in a structurally growing industry, ResMed has posted an average return on invested capital, or ROIC, of 20% over the last decade. We ...
-- The January seasonal trade has begun. Here's how you can master it. Sign up here to get MarketWatch's highlights of the most timely ETF news emailed to you weekly! Subjecting the Super Bowl ...
Canada can circumvent US-controlled patents, freeing up Canadian companies to make patented drugs as well as develop AI-based inventions and other key technologies.